Literature DB >> 17118103

Screening for sleep-related breathing disorders by transthoracic impedance recording integrated into a Holter ECG system.

Andreas Mueller1, Ingo Fietze, Richard Voelker, Stephan Eddicks, Martin Glos, Gert Baumann, Heinz Theres.   

Abstract

In patients with arrhythmias, coincidence with sleep-related breathing disorders (SRBD) is high and of clinical relevance. Electrocardiogram-derived (ECG) parameters have been developed for SRBD screening, but it has proved necessary to exclude patients with frequent arrhythmias. Holter-based screening tools, easy to use, are therefore warranted. The goal of our study was to evaluate the diagnostic accuracy, with respect to SRBD detection, of transthoracic impedance recording (TTIR) integrated into a Holter System. Our investigation consisted of 2 phases. In phase 1 we compared the performance of TTIR to that of in-hospital polysomnography (PSG) in 56 patients (46 male, mean age 57). In phase 2 we compared TTIR to results from an ambulatory polygraphy (PG) system in 180 patients (143 male, mean age 56). We scored apnea and hypopnea from P(S)G, and derived a respiratory-disturbance index (P(S)G-RDI). TTIR was analyzed semi-automatically. Reduction of the impedance amplitude by more than 50% over 10 s was scored as apnea/hypopnea, with consequent calculation of TTIR-RDI. In phase 1, 20 out of 56 patients revealed a PSG-RDI > 10 h(-1). TTIR-RDI in 19 patients from this group was >10 h(-1) (sensitivity 95%, specificity 97.2%, positive predictive value 95%, negative predictive value 97.2%, interclass correlation coefficient 0.98). In phase 2, 46 of 180 patients revealed a PSG-RDI > 10 h(-1). TTIR-RDI in 37 out of this group was >10 h(-1) (sensitivity 80.4%, specificity 92.5%, positive predictive value 78.7%, negative predictive value 93.2%, interclass correlation coefficient 0.92). TTIR integrated into a Holter ECG system and tested in a large patient cohort demonstrates acceptable high accuracy in detection of SRBD. Arrhythmia analysis and screening for SRBD can be performed in a single-step approch.

Entities:  

Mesh:

Year:  2006        PMID: 17118103     DOI: 10.1111/j.1365-2869.2006.00554.x

Source DB:  PubMed          Journal:  J Sleep Res        ISSN: 0962-1105            Impact factor:   3.981


  7 in total

Review 1.  Obstructive sleep apnea devices for out-of-center (OOC) testing: technology evaluation.

Authors:  Nancy A Collop; Sharon L Tracy; Vishesh Kapur; Reena Mehra; David Kuhlmann; Sam A Fleishman; Joseph M Ojile
Journal:  J Clin Sleep Med       Date:  2011-10-15       Impact factor: 4.062

2.  [Screening for sleep apnea in cardiovascular patients in clinical routine].

Authors:  W S Mäuser; S Sandrock; L Kotzott; H Bonnemeier
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2012-03

3.  Use of high-frequency peak in spectral analysis of heart rate increment to improve screening of obstructive sleep apnoea.

Authors:  Laurent Poupard; Isabelle Court-Fortune; Vincent Pichot; Florian Chouchou; Jean-Claude Barthélémy; Frédéric Roche
Journal:  Sleep Breath       Date:  2010-11-21       Impact factor: 2.816

4.  Multi-modal ECG Holter system for sleep-disordered breathing screening: a validation study.

Authors:  Laurent Poupard; Marc Mathieu; Michael Goldman; Florian Chouchou; Frédéric Roche
Journal:  Sleep Breath       Date:  2011-07-26       Impact factor: 2.816

5.  Home Sleep Testing of Sleep Apnea.

Authors:  Martin Glos; Dora Triché
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

6.  The predictive value of Holter monitoring in the risk of obstructive sleep apnea.

Authors:  Miaochan Lao; Qiong Ou; Cui'e Li; Qian Wang; Ping Yuan; Yilu Cheng
Journal:  J Thorac Dis       Date:  2021-03       Impact factor: 2.895

7.  Sleep-Disordered Breathing in Acute Ischemic Stroke: A Mechanistic Link to Peripheral Endothelial Dysfunction.

Authors:  Nadja Scherbakov; Anja Sandek; Nicole Ebner; Miroslava Valentova; Alexander Heinrich Nave; Ewa A Jankowska; Jörg C Schefold; Stephan von Haehling; Stefan D Anker; Ingo Fietze; Jochen B Fiebach; Karl Georg Haeusler; Wolfram Doehner
Journal:  J Am Heart Assoc       Date:  2017-09-11       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.